Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H18O3 |
Molecular Weight | 198.2588 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H]1CC[C@@H](CC1)C(=O)CCC(O)=O
InChI
InChIKey=JOWMTYWOBJALGB-KYZUINATSA-N
InChI=1S/C11H18O3/c1-8-2-4-9(5-3-8)10(12)6-7-11(13)14/h8-9H,2-7H2,1H3,(H,13,14)/t8-,9-
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0030073 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11356916 |
PubMed
Title | Date | PubMed |
---|---|---|
A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide. | 2001 Jan |
|
Daily inhibition of postprandial hyperglycaemia with JTT-608, a novel oral antidiabetic agent, ameliorates pancreatic function in neonatally streptozotocin-treated rats. | 2005 Sep |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
U419K07BFP
Created by
admin on Sat Dec 16 08:42:56 GMT 2023 , Edited by admin on Sat Dec 16 08:42:56 GMT 2023
|
PRIMARY | |||
|
195137-72-5
Created by
admin on Sat Dec 16 08:42:56 GMT 2023 , Edited by admin on Sat Dec 16 08:42:56 GMT 2023
|
PRIMARY | |||
|
6919096
Created by
admin on Sat Dec 16 08:42:56 GMT 2023 , Edited by admin on Sat Dec 16 08:42:56 GMT 2023
|
PRIMARY |
ACTIVE MOIETY